ketanserin has been researched along with Atherogenesis in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study was designed to test the hypothesis that a small dose of ketanserin, which enhances baroreflex activity, prevents the early lesions of atherosclerosis." | 7.76 | Effects of low-dose ketanserin on atherosclerosis in rats and rabbits. ( Cai, GJ; Han, P; Li, L; Song, SW; Su, DF; Xie, HH; Yu, YS, 2010) |
| "The present study was designed to test the hypothesis that a small dose of ketanserin, which enhances baroreflex activity, prevents the early lesions of atherosclerosis." | 3.76 | Effects of low-dose ketanserin on atherosclerosis in rats and rabbits. ( Cai, GJ; Han, P; Li, L; Song, SW; Su, DF; Xie, HH; Yu, YS, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, YS | 1 |
| Xie, HH | 1 |
| Li, L | 1 |
| Song, SW | 1 |
| Han, P | 1 |
| Cai, GJ | 1 |
| Su, DF | 1 |
1 other study available for ketanserin and Atherogenesis
| Article | Year |
|---|---|
Effects of low-dose ketanserin on atherosclerosis in rats and rabbits.
Topics: Animals; Antihypertensive Agents; Atherosclerosis; Baroreflex; Blood Pressure; Female; Ketanserin; M | 2010 |